Featured/ MCK/ 08/25/2026 · 3:31 PM McKesson Buys Maryland CRO Precision Medicine Group in $2.25 Billion Deal Morgan Stanley calls McKesson’s $2.25B Precision Medicine buy a logical CRO addition unlocking a $25B oncology market.
